In vitro experiments demonstrate that transmigration of tumor cells results in the redistribution of tight junction proteins (occludin, claudin-5 and ZO-1), while inhibiting endothelial the Rho/ROCK signaling pathway prevents this TEM of SCLC and maintains the assembly of tight junction proteins. The gene discussed is RHO; the disease is neoplasm.